Overview

Invert-Prospective Phase II Randomized Trial of Involved Nodal Versus Elective Neck RadioTherapy

Status:
RECRUITING
Trial end date:
2028-07-01
Target enrollment:
Participant gender:
Summary
To determine the risk of solitary elective volume recurrence following involved nodal radiotherapy (INRT) versus elective nodal irradiation (ENI)
Phase:
PHASE2
Details
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborator:
National Cancer Institute (NCI)
Treatments:
Cetuximab
Cisplatin
Drug Therapy